Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
5.38
-0.25 (-4.44%)
Aug 1, 2025, 4:00 PM - Market closed
Accolade Market Cap
Pulmatrix has a market cap or net worth of $19.48 million as of August 1, 2025. Its market cap has increased by 154.56% in one year.
Market Cap
19.48M
Enterprise Value
11.77M
1-Year Change
154.56%
Ranking
Category
Stock Price
$5.38
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $19.48M, a decrease of -88.26%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 19.48M | -23.60% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | 40.94M | 138.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |